首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   64篇
  免费   5篇
  2021年   1篇
  2019年   1篇
  2018年   2篇
  2017年   1篇
  2016年   1篇
  2015年   1篇
  2013年   4篇
  2012年   2篇
  2011年   6篇
  2010年   3篇
  2009年   7篇
  2008年   10篇
  2007年   1篇
  2006年   4篇
  2005年   7篇
  2004年   3篇
  2003年   2篇
  2002年   3篇
  2001年   4篇
  1999年   2篇
  1987年   1篇
  1986年   2篇
  1984年   1篇
排序方式: 共有69条查询结果,搜索用时 15 毫秒
11.
Ability for selective extraction of copper and zinc from zinc concentrate using association of chemolithotrophic bacteria was investigated. In the presence of bacterial association, the rate of leaching of zinc, copper, and iron was increased 3-fold, 4–5-fold, and 2-fold, respectively. The results indicate the maximum dissolution rate for zinc, then followed by copperand iron. It was revealed that addition of Fe3+ 2 g/l resulted in reduction of iron leaching and in 3-fold increase of leaching rate of copper at constant dissolution rate of mineral zinc. It is suggested that the intensification of copper leaching is connected with the activity of sulfur-oxidizing bacteria able to activate the mineral surface via elimination of passivation layer of elemental sulfur. It was concluded that sulfur-oxidizing bacteria play a significant role in copper leaching from zinc concentrate. A unique strain of mesophile sulfur-oxidizing bacteria was isolated from leaching pulp of zinc concentrate; in the perspective, it may serve as efficient candidate for performing of selective extraction of copper from zinc concentrate.  相似文献   
12.
TMEFF2 is a type I transmembrane protein with two follistatin (FS) and one EGF‐like domain over‐expressed in prostate cancer; however its biological role in prostate cancer development and progression remains unclear, which may, at least in part, be explained by its proteolytic processing. The extracellular part of TMEFF2 (TMEFF2‐ECD) is cleaved by ADAM17 and the membrane‐retained fragment is further processed by the gamma‐secretase complex. TMEFF2 shedding is increased with cell crowding, a condition associated with the tumour microenvironment, which was mediated by oxidative stress signalling, requiring jun‐kinase (JNK) activation. Moreover, we have identified that TMEFF2 is also a novel substrate for other proteases implicated in prostate cancer, including two ADAMs (ADAM9 and ADAM12) and the type II transmembrane serine proteinases (TTSPs) matriptase‐1 and hepsin. Whereas cleavage by ADAM9 and ADAM12 generates previously identified TMEFF2‐ECD, proteolytic processing by matriptase‐1 and hepsin produced TMEFF2 fragments, composed of TMEFF2‐ECD or FS and/or EGF‐like domains as well as novel membrane retained fragments. Differential TMEFF2 processing from a single transmembrane protein may be a general mechanism to modulate transmembrane protein levels and domains, dependent on the repertoire of ADAMs or TTSPs expressed by the target cell.  相似文献   
13.
Enoyl-ACP reductase is a catalytic component of the fatty acid synthetase (FAS) type II system in plants that is involved in the de novo fatty acid biosynthesis in plastids. A cDNA encoding an enoyl-ACP reductase responsible for the removal of the trans-unsaturated double bonds to form saturated acyl-ACP has been isolated from a library made from ripening fruits of Olea europaea L. The predicted protein contains 393 amino acid residues including a consensus chloroplast specific transit peptide. A strong homology was observed when olive enoyl-ACP reductase aligned with other plant sequences. Southern hybridization analysis revealed that enoyl-ACP reductase is encoded by a single gene in olives. Northern hybridization showed a transient expression of the enoyl-ACP reductase (ENR) gene at early stages of drupe (5-7 weeks after flowering, WAF), embryo and endosperm (13-16 WAF) while in mesocarp (13-19 WAF) the expression remained at high levels. In situ hybridization showed particularly prominent expression in the palisade and vascular tissue of young leaves, the tapetum, developing pollen grains and vascular tissue of anthers and to less extent in the embryo sac and transmitting tissue of the carpel. The distinctive spatial and temporal regulation of the ENR gene is consistent with major roles, not only in thylakoid membrane formation and fatty acid deposition, but also in the provision of precursor molecules for the biosynthesis of oxilipins that are important in plant tissues involved in transportation and reproduction.  相似文献   
14.
15.
AimsCannabinoid CB2 agonists have been shown to alleviate behavioral signs of inflammatory and neuropathic pain in animal models. AM1241, a CB2 agonist, does not demonstrate central nervous system side effects seen with CB1 agonists such as hypothermia and catalepsy. Metastatic bone cancer causes severe pain in patients and is treated with analgesics such as opiates. Recent reports suggest that sustained opiates can produce paradoxical hyperalgesic actions and enhance bone destruction in a murine model of bone cancer. In contrast, CB2 selective agonists have been shown to reduce bone loss associated with a model of osteoporosis. Here we tested whether a CB2 agonist administered over a 7 day period inhibits bone cancer-induced pain as well as attenuates cancer-induced bone degradation.Main methodsA murine bone cancer model was used in which osteolytic sarcoma cells were injected into the intramedullary space of the distal end of the femur. Behavioral and radiographic image analysis was performed at days 7, 10 and 14 after injection of tumor cells into the femur.Key findingsOsteolytic sarcoma within the femur produced spontaneous and touch evoked behavioral signs of pain within the tumor-bearing limb. The systemic administration of AM1241 acutely or for 7 days significantly attenuated spontaneous and evoked pain in the inoculated limb. Sustained AM1241 significantly reduced bone loss and decreased the incidence of cancer-induced bone fractures.SignificanceThese findings suggest a novel therapy for cancer-induced bone pain, bone loss and bone fracture while lacking many unwanted side effects seen with current treatments for bone cancer pain.  相似文献   
16.
Acids 9af as possible bivalent ligands designed as a structural combination of opioid μ-agonist (Fentanyl) and NSAID (Indomethacin) activities and produced compounds which were tested as analgesics. The obtained series of compounds exhibits low affinity and activity both at opioid receptors and as cyclooxygenase (COX) inhibitors. One explanation of the weak opioid activity could be stereochemical peculiarities of these bivalent compounds which differ significantly from the fentanyl skeleton. The absence of significant COX inhibitory properties could be explained by the required substitution of an acyl fragment in the indomethacin structure for 4-piperidyl.  相似文献   
17.
L-Phenylalanine ammonia-lyase (PAL, EC 4.3.1.5) of the Rhodotorula aurantiaca strain KM-1 deaminates L-phenylalanine according to the Michaelis-Menten kinetics with K M 1.75 ± 0.44 mM and V max 3.01 ± 0.43 units/mg. The enzyme is competitively inhibited by D-phenylalanine with K i 3.38 ± 0.32 mM. The Michaelis-Menten kinetics was analyzed, the inhibition type (competitive, noncompetitive, and mixed) was identified, and corresponding kinetic parameters were calculated using the computer programs written in Gauss 4.0. PAL was most stable at pH 6.55 and lacked approximately 50% of its activity after incubation at 57°C for 15 min. The yield of L-phenylalanine increased in the presence of mercaptoethanol, sodium ethylenediaminetetraacetate (EDTA), and ascorbic acid. The effects of EDTA and ascorbic acid were additive.  相似文献   
18.
The main characteristics of a periodic bioleaching of the refractory gold-bearing pyrite ore from the Tandzut deposit (Armenia) with the help of moderate thermophilic bacterium Sulfobacillus thermosulfidooxidans subsp. asporogenes and original thermotolerant strains Leptospirillum spp. were studied. The optimal pH for oxidizing the ore by S. thermosulfidooxidans subsp. asporogenes was 1.8; the pulp density providing maximal iron leaching rate was 10%. The intensity of oxidation processes decreased at higher ore concentrations. When using S. thermosulfidooxidans subsp. asporogenes, the largest amount of iron passed into the solution at the initial oxidant (Fe3+) concentration of 1.3 g/l. Cocultivation of S. thermosulfidooxidans subsp. asporogenes and Leptospirillum spp. increased the degree of pyrite ore leaching to 98.4% vs. 34.1% in the case of the former bacterium alone.  相似文献   
19.
Although there is a consensus that mitochondrial function is somehow linked to the aging process, the exact role played by mitochondria in this process remains unresolved. The discovery that reduced activity of the mitochondrial enzyme CLK-1/MCLK1 (also known as COQ7) extends lifespan in both Caenorhabditis elegans and mice has provided a genetic model to test mitochondrial theories of aging. We have recently shown that the mitochondria of young, long-lived, Mclk1+/− mice are dysfunctional, exhibiting reduced energy metabolism and a substantial increase in oxidative stress. Here we demonstrate that this altered mitochondrial condition in young animals paradoxically results in an almost complete protection from the age-de pend ent loss of mitochondrial function as well as in a significant attenuation of the rate of development of oxidative biomarkers of aging. Moreover, we show that reduction in MCLK1 levels can also gradually prevent the deterioration of mitochondrial function and associated increase of global oxidative stress that is normally observed in Sod2+/− mutants. We hypothesize that the mitochondrial dysfunction observed in young Mclk1+/− mutants induces a physiological state that ultimately allows for their slow rate of aging. Thus, our study provides for a unique vertebrate model in which an initial alteration in a specific mitochondrial function is linked to long term beneficial effects on biomarkers of aging and, furthermore, provides for new evidence which indicates that mitochondrial oxidative stress is not causal to aging.Because it is well known that the aging process is characterized by declines in basal metabolic rate and in the general performance of energy-dependent processes, many aging studies have focused on mitochondria because of their central role in producing chemical energy (ATP) by oxidative phosphorylation (1). Among the various theories of aging that have been proposed, the mitochondrial oxidative stress theory of aging is the most widely acknowledged and studied (24). It is based on the observation that mitochondrial energy metabolism produces reactive oxygen species (ROS),2 that mitochondrial components are damaged by ROS, that mitochondrial function is progressively lost during aging, and that the progressive accumulation of global oxidative damage is strongly correlated with the aged phenotype. However, the crucial question of whether these facts mean that mitochondrial dysfunction and the related ROS production cause aging remains unproven (57). Furthermore, recent observations made in various species, including mammals, have begun to directly challenge this hypothesis, notably by relating oxidative stress to long (8) or increased (9) lifespans, by demonstrating that overexpression of the main antioxidant enzymes does not extend lifespan (10) as well as by showing that mitochondrial dysfunction could protect against age-related diseases (11).A direct and powerful approach to attempt to clarify this major question and to test the theory is to characterize the mitochondrial function of long-lived mutants (12). CLK-1/MCLK1 is an evolutionary conserved protein (13) and has been found to be located in the mitochondria of yeast (14), worms (15), and mice (16). The inactivation of the Caenorhabditis elegans gene clk-1 substantially increases lifespan (17). Moreover, the elimination of one functional allele of its murine orthologue also resulted in an extended longevity for Mclk1+/− mice in three distinct genetic backgrounds (18). These findings have provided for an evolutionarily conserved pathways of animal aging that is affected by the function of a mitochondrial protein (19, 20). In mitochondria CLK1/MCLK1 acts as an hydroxylase and is implicated in the biosynthesis of ubiquinone (coenzyme Q or UQ), a lipid-like molecule primarily known as an electron carrier in the mitochondrial respiratory chain and as a membrane antioxidant but which is also associated with an increasing number of different aspects of cellular metabolism (20, 21). Taken together, these observations indicate that the long-lived Mclk1+/− mouse is a model of choice for the understanding of the links between mitochondrial energy metabolism, oxidative stress, and the aging process in mammals.Previous analysis of Mclk1+/− mice, which show the expected reduction of MCLK1 protein levels (22), have revealed that their tissues as well as their mitochondria contain normal levels of UQ at 3 months of age (23). Yet the same study also revealed a host of phenotypes induced by Mclk1 heterozygosity (see below). Thus, it appears that MCLK1 has an additional function that is unrelated to UQ biosynthesis but responsible for the phenotypes observed in young Mclk1+/− mutants. This is consistent with several results from nematodes which also strongly suggest that CLK-1 has other functions (24, 25).In depth characterization of the phenotype of young Mclk1+/− mutants has revealed that the reduction of MCLK1 levels in these animals profoundly alters their mitochondrial function despite the fact that UQ production is unaffected (23). In fact, we have shown that Mclk1 heterozygosity induces a severe impairment of mitochondrial energy metabolism as revealed by a reduction in the rates of mitochondrial electron transport and oxygen consumption as well as in ATP synthesis and ATP levels in both the mitochondria and the whole cell. ATP levels in several organs were surprisingly strongly affected with, for example, a 50% reduction of overall cellular ATP levels in the livers of Mclk1+/− mutants (23). Moreover, we have found that the Mclk1+/− mice sustain high mitochondrial oxidative stress by a variety of measurements, including aconitase activity, protein carbonylation, and ROS production (23). Additionally, we have shown that this early mitochondrial dysfunction is associated with a reduction in some aspects of cytosolic oxidative damage and global oxidative stress that can be measured via recognized plasma biomarkers such as 8-isoprostanes and 8-hydroxy-2-deoxyguanosine (8-OHdG). Considering that the accumulation of global oxidative damage is known to be tightly linked to the aging process (26), this latter result suggests that the anti-aging effect triggered by low MCLK1 levels might already act at a young age.To further investigate the clk-1/Mclk1-dependent mechanism of aging as well as to try to elucidate the still unclear relation between mitochondrial dysfunction, oxidative stress, and aging, we have now carefully analyzed the evolution of the phenotype of Mclk1+/− mutants over time. We have also studied the effects of reduced MCLK1 levels on the phenotype of mice heterozygous for the mitochondrial superoxide dismutase (Sod2), which represent a well known model of mitochondrial oxidative stress (27). In addition of confirming the long lifespan phenotype of the Mclk1+/− mutants in a mixed background (129S6 x BALB/c), we also report here a study of mutants and controls on a completely isogenic background where we find that the condition of Mclk1+/− mutants unexpectedly results in protection against the age-dependent loss of mitochondrial function. Moreover, we found that the mutants are characterized by a significant attenuation of the age-associated increase in global oxidative stress normally observed in mammals. We also show that the Mclk1+/− condition can gradually reverse the deterioration of mitochondrial function and the associated increase of global oxidative stress that is normally observed in Sod2+/− mutants. Thus, this study provides for a unique vertebrate model in which reduced levels of a specific mitochondrial protein causes early mitochondrial dysfunction but has long term beneficial effects that slow down the rate of aging, as established with appropriate biomarkers, and can ultimately prolong lifespan in mice. Furthermore, in line with recent studies that have raised doubts about the validity of the mitochondrial oxidative stress theory of aging (4, 8, 10), our results, which relate to a recognized long-lived mice model, represent a novel and crucial indication that mitochondrial oxidative stress might not by itself be causal to aging.  相似文献   
20.
Living organisms have evolved intricate systems to harvest trace elements from the environment, to control their intracellular levels, and to ensure adequate delivery to the various organs and cellular compartments. Copper is one of these trace elements. It is at the same time essential for life but also highly toxic, not least because it facilitates the generation of reactive oxygen species. In mammals, copper uptake in the intestine and copper delivery into other organs are mediated by the copper importer Ctr1. Drosophila has three Ctr1 homologs: Ctr1A, Ctr1B, and Ctr1C. Earlier work has shown that Ctr1A is an essential gene that is ubiquitously expressed throughout development, whereas Ctr1B is responsible for efficient copper uptake in the intestine. Here, we characterize the function of Ctr1C and show that it functions as a copper importer in the male germline, specifically in maturing spermatocytes and mature sperm. We further demonstrate that loss of Ctr1C in a Ctr1B mutant background results in progressive loss of male fertility that can be rescued by copper supplementation to the food. These findings hint at a link between copper and male fertility, which might also explain the high Ctr1 expression in mature mammalian spermatozoa. In both mammals and Drosophila, the X chromosome is known to be inactivated in the male germline. In accordance with such a scenario, we provide evidence that in Drosophila, the autosomal Ctr1C gene originated as a retrogene copy of the X-linked Ctr1A, thus maintaining copper delivery during male spermatogenesis.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号